380 related articles for article (PubMed ID: 25914166)
1. An attenuated phenotype of Costello syndrome in three unrelated individuals with a HRAS c.179G>A (p.Gly60Asp) mutation correlates with uncommon functional consequences.
Gripp KW; Sol-Church K; Smpokou P; Graham GE; Stevenson DA; Hanson H; Viskochil DH; Baker LC; Russo B; Gardner N; Stabley DL; Kolbe V; Rosenberger G
Am J Med Genet A; 2015 Sep; 167A(9):2085-97. PubMed ID: 25914166
[TBL] [Abstract][Full Text] [Related]
2. Attenuated phenotype of Costello syndrome and early death in a patient with an HRAS mutation (c.179G>T; p.Gly60Val) affecting signalling dynamics.
Gripp KW; Kolbe V; Brandenstein LI; Rosenberger G
Clin Genet; 2017 Sep; 92(3):332-337. PubMed ID: 28139825
[TBL] [Abstract][Full Text] [Related]
3. Functional analysis of a duplication (p.E63_D69dup) in the switch II region of HRAS: new aspects of the molecular pathogenesis underlying Costello syndrome.
Lorenz S; Lissewski C; Simsek-Kiper PO; Alanay Y; Boduroglu K; Zenker M; Rosenberger G
Hum Mol Genet; 2013 Apr; 22(8):1643-53. PubMed ID: 23335589
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic spectrum of Costello syndrome individuals harboring the rare HRAS mutation p.Gly13Asp.
Bertola D; Buscarilli M; Stabley DL; Baker L; Doyle D; Bartholomew DW; Sol-Church K; Gripp KW
Am J Med Genet A; 2017 May; 173(5):1309-1318. PubMed ID: 28371260
[TBL] [Abstract][Full Text] [Related]
5. Costello syndrome: a Ras/mitogen activated protein kinase pathway syndrome (rasopathy) resulting from HRAS germline mutations.
Gripp KW; Lin AE
Genet Med; 2012 Mar; 14(3):285-92. PubMed ID: 22261753
[TBL] [Abstract][Full Text] [Related]
6. A novel HRAS c.466C>T p.(Phe156Leu) variant in two patients with attenuated features of Costello syndrome.
Lindsey-Temple S; Edwards M; Rickassel V; Nauth T; Rosenberger G
Eur J Hum Genet; 2022 Sep; 30(9):1088-1093. PubMed ID: 35764878
[TBL] [Abstract][Full Text] [Related]
7. Craniofacial and dental development in Costello syndrome.
Goodwin AF; Oberoi S; Landan M; Charles C; Massie JC; Fairley C; Rauen KA; Klein OD
Am J Med Genet A; 2014 Jun; 164A(6):1425-30. PubMed ID: 24668879
[TBL] [Abstract][Full Text] [Related]
8. Retinal dystrophy in two boys with Costello syndrome due to the HRAS p.Gly13Cys mutation.
Pierpont ME; Richards M; Engel WK; Mendelsohn NJ; Summers CG
Am J Med Genet A; 2017 May; 173(5):1342-1347. PubMed ID: 28337834
[TBL] [Abstract][Full Text] [Related]
9. Transmission of the rare HRAS mutation (c. 173C > T; p.T58I) further illustrates its attenuated phenotype.
Gripp KW; Hopkins E; Serrano A; Leonard NJ; Stabley DL; Sol-Church K
Am J Med Genet A; 2012 May; 158A(5):1095-101. PubMed ID: 22488832
[TBL] [Abstract][Full Text] [Related]
10. HRAS mutations in Costello syndrome: detection of constitutional activating mutations in codon 12 and 13 and loss of wild-type allele in malignancy.
Estep AL; Tidyman WE; Teitell MA; Cotter PD; Rauen KA
Am J Med Genet A; 2006 Jan; 140(1):8-16. PubMed ID: 16372351
[TBL] [Abstract][Full Text] [Related]
11. A very mild phenotype in six individuals of a three-generation family with the novel HRAS variant c.176C > G p.(Ala59Gly): Emergence of a new HRAS-related RASopathy distinct from Costello syndrome.
Frey T; Ivanovski I; Bahr A; Zweier M; Laube J; Luchsinger I; Steindl K; Rauch A
Am J Med Genet A; 2023 Aug; 191(8):2074-2082. PubMed ID: 37194190
[TBL] [Abstract][Full Text] [Related]
12. Costello syndrome and related disorders.
Quezada E; Gripp KW
Curr Opin Pediatr; 2007 Dec; 19(6):636-44. PubMed ID: 18025929
[TBL] [Abstract][Full Text] [Related]
13. Duplication of Glu37 in the switch I region of HRAS impairs effector/GAP binding and underlies Costello syndrome by promoting enhanced growth factor-dependent MAPK and AKT activation.
Gremer L; De Luca A; Merbitz-Zahradnik T; Dallapiccola B; Morlot S; Tartaglia M; Kutsche K; Ahmadian MR; Rosenberger G
Hum Mol Genet; 2010 Mar; 19(5):790-802. PubMed ID: 19995790
[TBL] [Abstract][Full Text] [Related]
14. Costello syndrome associated with novel germline HRAS mutations: an attenuated phenotype?
Gripp KW; Innes AM; Axelrad ME; Gillan TL; Parboosingh JS; Davies C; Leonard NJ; Lapointe M; Doyle D; Catalano S; Nicholson L; Stabley DL; Sol-Church K
Am J Med Genet A; 2008 Mar; 146A(6):683-90. PubMed ID: 18247425
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic analysis of individuals with Costello syndrome due to HRAS p.G13C.
Gripp KW; Hopkins E; Sol-Church K; Stabley DL; Axelrad ME; Doyle D; Dobyns WB; Hudson C; Johnson J; Tenconi R; Graham GE; Sousa AB; Heller R; Piccione M; Corsello G; Herman GE; Tartaglia M; Lin AE
Am J Med Genet A; 2011 Apr; 155A(4):706-16. PubMed ID: 21438134
[TBL] [Abstract][Full Text] [Related]
16. HRAS mutants identified in Costello syndrome patients can induce cellular senescence: possible implications for the pathogenesis of Costello syndrome.
Niihori T; Aoki Y; Okamoto N; Kurosawa K; Ohashi H; Mizuno S; Kawame H; Inazawa J; Ohura T; Arai H; Nabatame S; Kikuchi K; Kuroki Y; Miura M; Tanaka T; Ohtake A; Omori I; Ihara K; Mabe H; Watanabe K; Niijima S; Okano E; Numabe H; Matsubara Y
J Hum Genet; 2011 Oct; 56(10):707-15. PubMed ID: 21850009
[TBL] [Abstract][Full Text] [Related]
17. Molecular confirmation of HRAS p.G12S in siblings with Costello syndrome.
Gripp KW; Stabley DL; Geller PL; Hopkins E; Stevenson DA; Carey JC; Sol-Church K
Am J Med Genet A; 2011 Sep; 155A(9):2263-8. PubMed ID: 21834037
[TBL] [Abstract][Full Text] [Related]
18. Dermatological phenotype in Costello syndrome: consequences of Ras dysregulation in development.
Siegel DH; Mann JA; Krol AL; Rauen KA
Br J Dermatol; 2012 Mar; 166(3):601-7. PubMed ID: 22098123
[TBL] [Abstract][Full Text] [Related]
19. Costello syndrome: Clinical phenotype, genotype, and management guidelines.
Gripp KW; Morse LA; Axelrad M; Chatfield KC; Chidekel A; Dobyns W; Doyle D; Kerr B; Lin AE; Schwartz DD; Sibbles BJ; Siegel D; Shankar SP; Stevenson DA; Thacker MM; Weaver KN; White SM; Rauen KA
Am J Med Genet A; 2019 Sep; 179(9):1725-1744. PubMed ID: 31222966
[TBL] [Abstract][Full Text] [Related]
20. Paternal uniparental disomy with segmental loss of heterozygosity of chromosome 11 are hallmark characteristics of syndromic and sporadic embryonal rhabdomyosarcoma.
Robbins KM; Stabley DL; Holbrook J; Sahraoui R; Sadreameli A; Conard K; Baker L; Gripp KW; Sol-Church K
Am J Med Genet A; 2016 Dec; 170(12):3197-3206. PubMed ID: 27589201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
